These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8790165)

  • 1. Hypoplastic myelodysplasia (MDS).
    Geary CG; Marsh JC; Gordon-Smith EC
    Br J Haematol; 1996 Sep; 94(3):582-3. PubMed ID: 8790165
    [No Abstract]   [Full Text] [Related]  

  • 2. The differential diagnosis between aplastic anemia and hypocellular myelodysplasia in patients with pancytopenia.
    Lorand-Metze I; Meira DG; Lima CS; Vassallo J; Metze K
    Haematologica; 1999 Jun; 84(6):564-5. PubMed ID: 10366807
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential diagnosis between aplastic anemia and hypoplastic myelodysplastic syndromes: from the viewpoint of pediatrics].
    Hama A; Ito M; Kojima S
    Rinsho Ketsueki; 2012 Oct; 53(10):1485-91. PubMed ID: 23037720
    [No Abstract]   [Full Text] [Related]  

  • 4. [Thoughts on differential diagnosis between aplastic anemia and hypoplastic myelodysplastic syndrome].
    Shi J; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):910-2. PubMed ID: 24171972
    [No Abstract]   [Full Text] [Related]  

  • 5. Aplastic anaemia versus hypocellular myelodysplastic syndrome.
    Varma N; Varma S; Marwaha N; Garewal G
    Indian J Cancer; 1995 Sep; 32(3):110-5. PubMed ID: 8772810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy may unmask hypoplastic myelodysplastic syndrome that mimics aplastic anemia.
    Konoplev S; Medeiros LJ; Lennon PA; Prajapati S; Kanungo A; Lin P
    Cancer; 2007 Oct; 110(7):1520-6. PubMed ID: 17701956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of marrow CD34+ cells: An important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia.
    Orazi A
    Leukemia; 2006 Nov; 20(11):2041; author reply 2041-2. PubMed ID: 16990766
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia.
    Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T
    Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoplastic myelodysplastic syndrome associated with der(1;7)(q10;p10) presenting as bone marrow failure.
    Cho SY; Oh SH; Suh JT; Lee HJ; Lee WI; Baek SK; Cho KS; Park TS
    Acta Haematol; 2011; 126(2):110-3. PubMed ID: 21646778
    [No Abstract]   [Full Text] [Related]  

  • 10. Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia.
    Lew JL; Fenderson JL; Carmichael MG
    Hawaii J Med Public Health; 2017 Nov; 76(11 Suppl 2):10-12. PubMed ID: 29164009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematological characteristics of hypoplastic MDS patients with chromosomal abnormalities, who had been followed for aplastic anemia with normal karyotypes].
    Tamai Y; Takami H; Nakahata R; Nakui Y; Suzuki Y; Akagi T; Kariya K; Tsushima K; Munakata A; Kawamura S
    Rinsho Ketsueki; 1997 Dec; 38(12):1243-8. PubMed ID: 9455142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myelodysplastic syndrome mimicking sequentially an idiopathic thrombocytopenia purpura and an aplastic pancytopenia].
    Román A; Cabello A; Soto C; Olavarría E; Sánchez Fayos J
    Sangre (Barc); 1994 Jun; 39(3):226. PubMed ID: 7940055
    [No Abstract]   [Full Text] [Related]  

  • 13. Consensus Conference on the Treatment of Aplastic Anemia.
    Kojima S; Nakao S; Tomonaga M; Hows J; Marsh J; Gerard S; Bacigalupo A; Mizoguchi H
    Int J Hematol; 2000 Jul; 72(1):118-23. PubMed ID: 10979223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypoplastic myelodysplastic syndrome progressing to acute myelocytic leukemia (M2) after treatment with G-CSF and immunosuppressants].
    Miyata A; Deguchi S; Kikuchi T; Osada T; Sanada H
    Rinsho Ketsueki; 1998 Jun; 39(6):453-9. PubMed ID: 9695675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atypical clinical course of aplastic anemia in childhood from hemopoietic dysplasia].
    Ohara A; Tsuchida M; Tsukimoto I; Nakayama K; Hanawa Y
    Rinsho Ketsueki; 1987 Apr; 28(4):616-23. PubMed ID: 3626052
    [No Abstract]   [Full Text] [Related]  

  • 16. [Frequent transformation to overt myelodysplastic syndrome in patients with aplastic anemia showing hematopoietic monoclonality at onset].
    Murai K; Numaoka H
    Rinsho Ketsueki; 2000 May; 41(5):391-6. PubMed ID: 10879097
    [No Abstract]   [Full Text] [Related]  

  • 17. Myelodysplastic syndrome and aplastic anemia--diagnostic and conceptual uncertainties.
    Barrett J
    Leuk Res; 2000 Jul; 24(7):595-6. PubMed ID: 10867134
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immune-mediated bone marrow failure].
    Nakao S
    Rinsho Ketsueki; 2007 Jan; 48(1):19-25. PubMed ID: 17313073
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and treatment of aplastic anemia and lower-risk myelodysplastic neoplasms].
    Suzuki T
    Rinsho Ketsueki; 2024; 65(9):884-891. PubMed ID: 39358287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aplastic anemia & MDS International Foundation (AA&MDSIF): Bone Marrow Failure Disease Scientific Symposium 2010.
    Malcovati L; de Latour RP; Risitano A
    Leuk Res; 2011 Mar; 35(3):291-4. PubMed ID: 21036397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.